Literature DB >> 10657252

Subcellular localization of proteasomes and their regulatory complexes in mammalian cells.

P Brooks1, G Fuertes, R Z Murray, S Bose, E Knecht, M C Rechsteiner, K B Hendil, K Tanaka, J Dyson, J Rivett.   

Abstract

Proteasomes can exist in several different molecular forms in mammalian cells. The core 20S proteasome, containing the proteolytic sites, binds regulatory complexes at the ends of its cylindrical structure. Together with two 19S ATPase regulatory complexes it forms the 26S proteasome, which is involved in ubiquitin-dependent proteolysis. The 20S proteasome can also bind 11S regulatory complexes (REG, PA28) which play a role in antigen processing, as do the three variable gamma-interferon-inducible catalytic beta-subunits (e.g. LMP7). In the present study, we have investigated the subcellular distribution of the different forms of proteasomes using subunit specific antibodies. Both 20S proteasomes and their 19S regulatory complexes are found in nuclear, cytosolic and microsomal preparations isolated from rat liver. LMP7 was enriched approximately two-fold compared with core alpha-type proteasome subunits in the microsomal preparations. 20S proteasomes were more abundant than 26S proteasomes, both in liver and cultured cell lines. Interestingly, some significant differences were observed in the distribution of different subunits of the 19S regulatory complexes. S12, and to a lesser extent p45, were found to be relatively enriched in nuclear fractions from rat liver, and immunofluorescent labelling of cultured cells with anti-p45 antibodies showed stronger labelling in the nucleus than in the cytoplasm. The REG was found to be localized predominantly in the cytoplasm. Three- to six-fold increases in the level of REG were observed following gamma-interferon treatment of cultured cells but gamma-interferon had no obvious effect on its subcellular distribution. These results demonstrate that different regulatory complexes and subpopulations of proteasomes have different distributions within mammalian cells and, therefore, that the distribution is more complex than has been reported for yeast proteasomes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10657252      PMCID: PMC1220835     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  38 in total

1.  Characterization of recombinant REGalpha, REGbeta, and REGgamma proteasome activators.

Authors:  C Realini; C C Jensen; Z Zhang; S C Johnston; J R Knowlton; C P Hill; M Rechsteiner
Journal:  J Biol Chem       Date:  1997-10-10       Impact factor: 5.157

2.  Catalytic properties of 26 S and 20 S proteasomes and radiolabeling of MB1, LMP7, and C7 subunits associated with trypsin-like and chymotrypsin-like activities.

Authors:  J Reidlinger; A M Pike; P J Savory; R Z Murray; A J Rivett
Journal:  J Biol Chem       Date:  1997-10-03       Impact factor: 5.157

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

Review 4.  The 26S proteasome: subunits and functions.

Authors:  K Tanaka; C Tsurumi
Journal:  Mol Biol Rep       Date:  1997-03       Impact factor: 2.316

5.  Expression and subcellular localization of mouse 20S proteasome activator complex PA28.

Authors:  A Soza; C Knuehl; M Groettrup; P Henklein; K Tanaka; P M Kloetzel
Journal:  FEBS Lett       Date:  1997-08-11       Impact factor: 4.124

6.  Proteasome activities decrease during dexamethasone-induced apoptosis of thymocytes.

Authors:  J Beyette; G G Mason; R Z Murray; G M Cohen; A J Rivett
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

7.  Resistance to diverse drugs and ultraviolet light conferred by overexpression of a novel human 26 S proteasome subunit.

Authors:  V Spataro; T Toda; R Craig; M Seeger; W Dubiel; A L Harris; C Norbury
Journal:  J Biol Chem       Date:  1997-11-28       Impact factor: 5.157

Review 8.  Endoplasmic reticulum degradation: reverse protein flow of no return.

Authors:  T Sommer; D H Wolf
Journal:  FASEB J       Date:  1997-12       Impact factor: 5.191

9.  Simultaneous binding of PA28 and PA700 activators to 20 S proteasomes.

Authors:  K B Hendil; S Khan; K Tanaka
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

10.  Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits.

Authors:  T A Griffin; D Nandi; M Cruz; H J Fehling; L V Kaer; J J Monaco; R A Colbert
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307

View more
  80 in total

1.  gamma-Interferon decreases the level of 26 S proteasomes and changes the pattern of phosphorylation.

Authors:  S Bose; P Brooks; G G Mason; A J Rivett
Journal:  Biochem J       Date:  2001-01-15       Impact factor: 3.857

2.  Association of immunoproteasomes with the endoplasmic reticulum.

Authors:  P Brooks; R Z Murray; G G Mason; K B Hendil; A J Rivett
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

3.  PI31 is a modulator of proteasome formation and antigen processing.

Authors:  Dietmar M W Zaiss; Sybille Standera; Peter-M Kloetzel; Alice J A M Sijts
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-08       Impact factor: 11.205

4.  Clastosome: a subtype of nuclear body enriched in 19S and 20S proteasomes, ubiquitin, and protein substrates of proteasome.

Authors:  Miguel Lafarga; Maria Teresa Berciano; Emma Pena; Isabel Mayo; Jose G Castaño; Dirk Bohmann; João Pedro Rodrigues; João Paulo Tavanez; Maria Carmo-Fonseca
Journal:  Mol Biol Cell       Date:  2002-08       Impact factor: 4.138

5.  PA200, a nuclear proteasome activator involved in DNA repair.

Authors:  Vicença Ustrell; Laura Hoffman; Gregory Pratt; Martin Rechsteiner
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

6.  Changes in the proteolytic activities of proteasomes and lysosomes in human fibroblasts produced by serum withdrawal, amino-acid deprivation and confluent conditions.

Authors:  Graciela Fuertes; José Javier Martín De Llano; Adoración Villarroya; A Jennifer Rivett; Erwin Knecht
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

Review 7.  Post-translational modification of cardiac proteasomes: functional delineation enabled by proteomics.

Authors:  Sarah B Scruggs; Nobel C Zong; Ding Wang; Enrico Stefani; Peipei Ping
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-20       Impact factor: 4.733

8.  Implications for proteasome nuclear localization revealed by the structure of the nuclear proteasome tether protein Cut8.

Authors:  Kojiro Takeda; Nam K Tonthat; Tiffany Glover; Weijun Xu; Eugene V Koonin; Mitsuhiro Yanagida; Maria A Schumacher
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-05       Impact factor: 11.205

9.  Amyloid β-induced FOXRED2 mediates neuronal cell death via inhibition of proteasome activity.

Authors:  SangMi Shim; WonJae Lee; HaeWon Chung; Yong-Keun Jung
Journal:  Cell Mol Life Sci       Date:  2010-10-23       Impact factor: 9.261

10.  Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein.

Authors:  Kohji Moriishi; Tamaki Okabayashi; Kousuke Nakai; Kyoji Moriya; Kazuhiko Koike; Shigeo Murata; Tomoki Chiba; Keiji Tanaka; Ryosuke Suzuki; Tetsuro Suzuki; Tatsuo Miyamura; Yoshiharu Matsuura
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.